Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1729-1736, October 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wogan, G. N.
Right arrow Articles by Shank, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wogan, G. N.
Right arrow Articles by Shank, R. C.

Excretion and Tissue Distribution of Radioactivity from Aflatoxin B1-14C in Rats1

G. N. Wogan, G. S. Edwards and R. C. Shank

Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

Excretion patterns of 14C derived from intraperitoneal doses of ring-labeled and methoxy-labeled aflatoxin B1 were investigated in male rats. It was found that 70–80% of the administered radioactivity from both compounds was excreted during the 24 hours following administration. A major excretory route of the ring-labeled material was through biliary excretion into feces, which accounted for nearly 60% of the administered 14C. A further 20% was excreted in urine, and only negligible amounts in CO2. In contrast, approximately 25% of administered radioactivity from the methoxy-labeled compound appeared in CO2 with a concomitant decrease in feces. These results indicate that O-demethylation represents a significant metabolic pathway for aflatoxin B1 in the rat.

Radioactivity derived from ring-labeled compound was present at maximum levels in liver and kidneys 0.5 hour after administration, with small amounts present in other organs. The concentration of radioactivity was five to fifteen times greater in liver than in other tissues, and at the end of 24 hours, the liver contained an amount equal to the content of the remainder of the carcass. This finding is associated with the relative tissue specificity of aflatoxin B1 as a hepatotoxin.

1 Contribution No. 967 from the Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Mass.

Received 1/17/67. Accepted 5/18/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.